| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.1 | 0.05 |